Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo Parallel-controlled Phase III Clinical Trial on the Efficacy and Safety of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome (Intermingled Cold and Heat).
Conditions
Interventions
Lianxiaxiaopi Granules
a simulated agent of Lianxiaxiaopi Granules
Locations
18
China
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China
Gansu Provincial Hospital of Traditional Chinese Medicine
Lanzhou, Gansu, China
The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Guiyang, Guizhou, China
Hebei Provincial Hospital of Traditional Chinese Medicine
Shijiazhuang, Hebei, China
The Second Affiliated Hospital of Xingtai Medical College
Xingtai, Hebei, China
Baoding No. 1 Hospital of Traditional Chinese Medicine
Baoding, Heibei, China
Start Date
February 27, 2025
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
January 20, 2026
NCT07174297
NCT02762136
Lead Sponsor
Tasly Pharmaceutical Group Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions